Literature DB >> 32492688

Prior Therapeutic Experiences, Not Expectation Ratings, Predict Placebo Effects: An Experimental Study in Chronic Pain and Healthy Participants.

Luana Colloca1,2,3, Titilola Akintola4,5, Nathaniel R Haycock4, Maxie Blasini4, Sharon Thomas4, Jane Phillips6, Nicole Corsi4, Lieven A Schenk4,5, Yang Wang4,5.   

Abstract

INTRODUCTION: Many clinical trials fail because of placebo responses. Prior therapeutic experiences and patients' expectations may affect the capacity to respond to placebos in chronic disorders.
OBJECTIVE: The scope of this study in 763 chronic orofacial pain and healthy study participants was to compare the magnitude and prevalence of placebo effects and determine the putative role of prior therapeutic experiences vs. expectations.
METHODS: We tested placebo propensity in a laboratory setting by using 2 distinct levels of individually tailored painful stimulations (high pain and low pain) to reinforce expectations and provide a hypoalgesic experience (conditioning phase). Afterwards, both levels of pain were surreptitiously set at a moderate pain level to test for placebo effects (testing phase). Pain and expectation ratings were assessed as primary outcomes using visual analog scales.
RESULTS: In both chronic pain and healthy participants, placebo effects were similar in magnitude, with the larger prevalence of responders in the healthy participants. Although chronic pain participants reported higher pain relief expectations, expectations did not account for the occurrence of placebo effects. Rather, prior experience via conditioning strength mediated placebo effects in both pain and healthy participants.
CONCLUSIONS: These findings indicate that participants with chronic pain conditions display robust placebo effects that are not mediated by expectations but are instead directly linked to prior therapeutic experiences. This confirms the importance of assessing the therapeutic history while raising questions about the utility of expectation ratings. Future research is needed to enhance prediction of responses to placebos, which will ultimately improve clinical trial designs.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Clinical research; Cognition; Conditioning; Psychology; Psychosomatic medicine

Mesh:

Year:  2020        PMID: 32492688      PMCID: PMC7581546          DOI: 10.1159/000507400

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  51 in total

1.  Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?

Authors:  Fabrizio Benedetti; Antonella Pollo; Luana Colloca
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

Review 2.  Temporomandibular disorders.

Authors:  Steven J Scrivani; David A Keith; Leonard B Kaban
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

3.  Waking-state oral parafunctional behaviors: specificity and validity as assessed by electromyography.

Authors:  Richard Ohrbach; Michael R Markiewicz; Willard D McCall
Journal:  Eur J Oral Sci       Date:  2008-10       Impact factor: 2.612

Review 4.  Orofacial pain and headache: a review and look at the commonalities.

Authors:  Steven D Bender
Journal:  Curr Pain Headache Rep       Date:  2014-03

5.  Altered placebo and drug labeling changes the outcome of episodic migraine attacks.

Authors:  Slavenka Kam-Hansen; Moshe Jakubowski; John M Kelley; Irving Kirsch; David C Hoaglin; Ted J Kaptchuk; Rami Burstein
Journal:  Sci Transl Med       Date:  2014-01-08       Impact factor: 17.956

6.  Placebo, nocebo, and learning mechanisms.

Authors:  Luana Colloca
Journal:  Handb Exp Pharmacol       Date:  2014

7.  Partial reinforcement, extinction, and placebo analgesia.

Authors:  Siu Tsin Au Yeung; Ben Colagiuri; Peter F Lovibond; Luana Colloca
Journal:  Pain       Date:  2014-03-03       Impact factor: 6.961

8.  Brain networks predicting placebo analgesia in a clinical trial for chronic back pain.

Authors:  Javeria A Hashmi; Alex T Baria; Marwan N Baliki; Lejian Huang; Thomas J Schnitzer; Vania A Apkarian
Journal:  Pain       Date:  2012-09-15       Impact factor: 6.961

9.  OPRM1 rs1799971, COMT rs4680, and FAAH rs324420 genes interact with placebo procedures to induce hypoalgesia.

Authors:  Luana Colloca; Yang Wang; Pedro E Martinez; Yen-Pei C Chang; Kathleen A Ryan; Colin Hodgkinson; David Goldman; Susan G Dorsey
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

10.  Open-label placebo treatment in chronic low back pain: a randomized controlled trial.

Authors:  Cláudia Carvalho; Joaquim Machado Caetano; Lidia Cunha; Paula Rebouta; Ted J Kaptchuk; Irving Kirsch
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

View more
  10 in total

Review 1.  The reward for placebos: mechanisms underpinning placebo-induced effects on motor performance.

Authors:  Cayque Brietzke; Julio Cesar Silva Cesario; Florentina Johanna Hettinga; Flavio Oliveira Pires
Journal:  Eur J Appl Physiol       Date:  2022-08-25       Impact factor: 3.346

2.  Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial.

Authors:  Etienne Vachon-Presseau; Taha B Abdullah; Sara E Berger; Lejian Huang; James W Griffith; Thomas J Schnitzer; A Vania Apkarian
Journal:  Pain       Date:  2022-05-01       Impact factor: 7.926

3.  Who are the placebo responders? A cross-sectional cohort study for psychological determinants.

Authors:  Yang Wang; Esther Chan; Susan G Dorsey; Claudia M Campbell; Luana Colloca
Journal:  Pain       Date:  2021-09-10       Impact factor: 7.926

4.  Association of nocebo hyperalgesia and basic somatosensory characteristics in a large cohort.

Authors:  Mari Hanna Feldhaus; Björn Horing; Christian Sprenger; Christian Büchel
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Associations Between Interindividual Differences, Expectations and Placebo and Nocebo Effects in Itch.

Authors:  Stefanie H Meeuwis; Henriët van Middendorp; Dieuwke S Veldhuijzen; Andrea W M Evers
Journal:  Front Psychol       Date:  2021-12-13

6.  Attitudes Toward a Pre-authorized Concealed Opioid Taper: A Qualitative Analysis of Patient and Clinician Perspectives.

Authors:  Theresa Bedford; Nkaku Kisaalita; Nathaniel R Haycock; C Daniel Mullins; Thelma Wright; Michele Curatolo; Lynette Hamlin; Luana Colloca
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 4.157

Review 7.  Quantitative Sensory Testing Across Chronic Pain Conditions and Use in Special Populations.

Authors:  Kristen R Weaver; Mari A Griffioen; N Jennifer Klinedinst; Elizabeth Galik; Ana C Duarte; Luana Colloca; Barbara Resnick; Susan G Dorsey; Cynthia L Renn
Journal:  Front Pain Res (Lausanne)       Date:  2022-01-28

8.  Observing treatment outcomes in other patients can elicit augmented placebo effects on pain treatment: a double-blinded randomized clinical trial with patients with chronic low back pain.

Authors:  Marie Schwartz; Laura-Marie Fischer; Corinna Bläute; Jan Stork; Luana Colloca; Christian Zöllner; Regine Klinger
Journal:  Pain       Date:  2021-12-17       Impact factor: 7.926

9.  Expectations: How and when do they contribute to placebo analgesia?

Authors:  Sophie Rosenkjær; Sigrid Juhl Lunde; Irving Kirsch; Lene Vase
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

10.  Conditioning to Enhance the Effects of Repetitive Transcranial Magnetic Stimulation on Experimental Pain in Healthy Volunteers.

Authors:  Léa Proulx-Bégin; Alberto Herrero Babiloni; Sabrina Bouferguene; Mathieu Roy; Gilles J Lavigne; Caroline Arbour; Louis De Beaumont
Journal:  Front Psychiatry       Date:  2022-02-22       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.